Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

  • Read more about Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

  • Read more about Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Eculizumab (Soliris) in Covid-19 Infected Patients

  • Read more about Eculizumab (Soliris) in Covid-19 Infected Patients

Safety and Immunity of Covid-19 aAPC Vaccine

  • Read more about Safety and Immunity of Covid-19 aAPC Vaccine

Bevacizumab in Patients With Severe Covid-19

  • Read more about Bevacizumab in Patients With Severe Covid-19

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

  • Read more about Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

NO Prevention of COVID-19 for Healthcare Providers

  • Read more about NO Prevention of COVID-19 for Healthcare Providers

Mechanisms for Organ Dysfunction in Covid-19

  • Read more about Mechanisms for Organ Dysfunction in Covid-19

Norwegian Coronavirus Disease 2019 Study

  • Read more about Norwegian Coronavirus Disease 2019 Study

Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)

  • Read more about Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 265
  • Page 266
  • Page 267
  • Page 268
  • Current page 269
  • Page 270
  • Page 271
  • Page 272
  • Page 273
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA